The American Society of Clinical Oncology (ASCO) annual meeting offers premier scientific events for oncology professionals, patient advocates, industry representatives and major media outlets worldwide.
The 2021 ASCO annual meeting, held virtually, provides an opportunity to learn about the latest developments in cancer science from Fred Hutchinson Cancer Research Center and research institutions around the world. The program features 175 sessions, including 48 with real-time engagement during scheduled broadcasts. All presentations are available starting on June 4 at 6 a.m. PDT unless otherwise noted.
Oral Presentation: Cancer diagnosis and adverse financial events: Evidence from credit reports
Oral Presentation: Medicaid patients more likely to die at home without hospice during the pandemic versus before, exacerbating disparities with commercially insured patients
Poster Presentation: Racial disparities in access to prostate cancer clinical trials: A county-level analysis
Presenter: Dr. Aasthaa Bansal
Abstract No. 6553
Oral Presentation: First-in-human phase I/II study of CYT-0851, a first-in-class inhibitor of RAD51-mediated homologous recombination in patients with advanced solid and hematologic cancers
Presenter: Dr. Ryan Lynch
Abstract No. 3006
Session Broadcast: June 4, 8 a.m. PDT
Poster Presentation: Concordance of DNA damage repair (DDR) gene mutations in paired primary and metastatic prostate cancer (PC) samples
Presenter: Dr. Michael T. Schweizer
Abstract No. 5020
Poster Discussion: PrE0807: A phase Ib feasibility trial of neoadjuvant nivolumab (N) without or with lirilumab (L) in cisplatin-ineligible patients (pts) with muscle-invasive bladder cancer (MIBC)
Presenter: Dr. Petros Grivas
Abstract No. 4518
Poster Presentation: CD19 CAR T-cell product type independently impacts CRS and ICANS severity in patients with aggressive NHL
Presenter: Dr. Jordan Gauthier
Abstract: No. 7532
Please email or call for more information or to arrange an interview.